Top Banner
with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo, Tamara Rader, Nancy Santesso, Holger Schunemann, Dawn Stacey, Vivian Welch and my Ottawa colleagues.
32

with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

Mar 20, 2018

Download

Documents

hoangtuong
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo, Tamara Rader, Nancy Santesso, Holger Schunemann, Dawn Stacey, Vivian Welch and my Ottawa colleagues.

Page 2: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

GRADE Clinical Practice Guidelines Summary –Key Points

1. GRADE is the approach used by WHO and gaining acceptance internationally 1. combines what is known in health research methodology and

provides a structured approach to improve communication

2. Guidelines should be based on the best available evidence to be evidence based

3. Does not avoid judgments but provides framework 4. Criteria for evidence assessment across questions and

outcomes 5. Criteria for moving from evidence to recommendations 6. Transparent, systematic

– four categories of quality of evidence – two grades for strength of recommendations

7. Transparency in decision making and judgments is key 8. Every group does not need to start anew: ADAPT [‘Triple C’

]

Page 3: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

GRADE Uptake World Health Organization Allergic Rhinitis in Asthma Guidelines (ARIA) American Thoracic Society American College of Physicians European Respiratory Society European Society of Thoracic Surgeons British Medical Journal Infectious Disease Society of America American College of Chest Physicians UpToDate® National Institutes of Health and Clinical Excellence (NICE) Scottish Intercollegiate Guideline Network (SIGN) Cochrane Collaboration Infectious Disease Society of America Clinical Evidence Agency for Health Care Research and Quality (AHRQ) Partner of GIN Over 60 major organizations

Page 4: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

International CPG Activities

Today -lets discuss this in the Croatian Context

? Try out the ‘Triple C’ idea

Guidelines that are ‘Cast in the Croatian Context’

Page 5: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

Clinical practice guidelines

PLEASE TURN TO THE PERSON NEXT TO YOU AND PROPOSE 1-2 KEY FEATURES OF A ‘GOOD CLINICAL PRACTICE GUIDELINE ‘! .

Page 6: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,
Page 7: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

8 Features of Good Clinical practice Guidelines

1. For specific clinical circumstances [‘foreground’]

PICO. 2. Systematically developed statements 3. To assist the ‘dyad’:practitioner and patient

decisions 4. About appropriate health care taking resources into

account. 5. Summarize the best available evidence 6. Weight the desirable and undesirable consequences 7. Integrate values and preferences 8. Easily understood by all

Page 8: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

LETS LOOK AT ‘GRADE’

Grades of Recommendation, Assessment, Development and Evaluation

Page 9: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

My recent guideline experiences using Cochrane Systematic Reviews

1. Primary Care for Immigrants and Refugees to Canada 2. Osteoarthritis -Primary Care [GI Effects] 3. Rheumatoid Arthritis management –when to use the expensive new

Biologics 4. Renal Dialysis 5. Eczema

After reviewing all the Guideline systems where we could use Cochrane SRs, we decided to use the ‘GRADE’ approach GRADE (Grades of Recommendation, Assessment, Development and Evaluation)

Adapt from other gps- in Canada : ‘Triple C ‘ [Cast in the Canadian Context] Recommend same approach for Croatia : ‘Triple C ‘[Cast in the Croatian Context]

Page 10: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

GRADE

(Grades of Recommendation, Assessment, Development and Evaluation)

• Why was GRADE needed?

Page 11: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

8 Features of Good Clinical practice Guidelines not met by most Guideline

Organisations

1. For specific clinical circumstances [‘foreground’] PICO. 2. Systematically developed statements 3. To assist the ‘dyad’:practitioner and patient decisions 4. About appropriate health care taking resources into

account. 5. Summarize the best available evidence 6. Weight the desirable and undesirable consequences 7. Integrate values and preferences 8. Easily understood by all

Page 12: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

Background

• WHO develops advice (recommendations) “all the time”

• Format differs, methods differ, much criticism • May 2005 World Health Assembly resolution

–WHO Director-General "to undertake an assessment of WHO's internal resources, expertise and activities in the area of health research, with a view to developing a position paper on WHO's role and responsibilities in the area of health research, and to report through the Executive Board to the next World Health Assembly."

Page 13: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

WHO guidelines were considered

not transparent

not evidence based

Oxman et al, Lancet 2007;369:1883-9

Page 14: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

In other words

↓ Systematic reviews

↓ Transparency about judgements

↑ Expert opinion confused with evidence

↑ Conflict of interest

↓ Adaptation of global guidelines to end users' needs

↔ Tension between time taken and when advice needed

↓ Resources

Page 15: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

Confusion of Classification by different organisations

Evidence Recommendation

• B Class I

• A 1

• IV C

Organization

AHA

ACCP

SIGN

Recommendation for use of oral anticoagulation in patients with atrial fibrillation and rheumatic mitral valve disease

Page 16: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

GRADE Working Group

Grades of Recommendation Assessment, Development and

Evaluation

CMAJ 2003, BMJ 2004, BMC 2004, BMC 2005, AJRCCM 2006, Chest 2006, BMJ 2008

• Aim: to develop (use and test) a common, transparent and sensible system for grading the quality of evidence and the strength of recommendations (over 100 systems)

• International group of guideline developers, epidemiologists, clinical researchers, public health officers, methodologists & clinicians from around the world (>300 contributors) – since 2000

Page 17: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

GRADE PROVIDES A STRUCTURED APPROACH TO IMPROVE

COMMUNICATION

1. Based on the best available evidence to be evidence based

2. Does not avoid judgments but provides framework

3. Criteria for evidence assessment across questions and outcomes

4. Criteria for moving from evidence to recommendations 5. Transparent, systematic

- four categories of quality of evidence -two grades for strength of recommendations

6. Transparency in decision making and judgments is key

Page 18: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

Systematic review

Guideline development

P I C O

Outcome

Outcome

Outcome

Outcome

Critical

Important

Critical

Not Summary of findings & estimate of effect for each outcome

Grade overall quality of evidence

across outcomes based on lowest quality

of critical outcomes

1. Risk of bias 2. Inconsistency 3. Indirectness 4. Imprecision 5. Publication

bias

Gra

de

do

wn

G

rad

e u

p 1. Large effect

2. Dose response

3. Opposing bias & Confounders

Very low

Low

Moderate

High

Grade recommendations •For or against (direction) •Strong or conditional/weak (strength) By considering balance of:

Quality of evidence Balance benefits/harms Values and preferences

Revise if necessary by considering: Resource use (cost)

Formulate Recommendations ( | …) •“We recommend using…” | “Clinicians should…” •“We suggest using…” | “Clinicians might…” •“We suggest not using…” | “Clinicians … not…” •“We recommend not using…”| “Clinicians should not…”

Guideline

OOO

O

OO

Page 19: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

Finally: Lets think about being clear about the

a] Benefits b]Harms of Clinical Practice Guidelines

Question for you -the audience! Please discuss with your neighbour

A] Patients: one benefit and one harm of guidelines to Patients

Page 20: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

?Potential benefits for patients

• .

Page 21: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

Potential benefits for patients

• improve health outcomes

• improve consistency of care

• summarise benefits and harms of treatment options (consumer guidelines)

• empower patients to make informed treatment choices

• help patients to influence policy Woolf et al (1999). British Medical Journal.

Page 22: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

?Potential harms for patients

• .

Page 23: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

Potential harms for patients

• flawed guidelines may result in sub optimal, ineffective or harmful practices

• inflexible guidelines may result in inappropriate care for individual patients

• consumer versions of guidelines may be inaccurate

• distort policy decisions

Woolf et al (1999). British Medical Journal.

Page 24: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

Question for you -the audience! Please discuss with your neighbour Identify 1 of each of the following:

Think of

A] Patients: one benefit and one harm of guidelines to Patients

B]Clinicians : one benefit and one harm of guidelines to Clinicians.

Page 25: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

?Potential benefits for Clinicians

• .

Page 26: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

Potential benefits for Clinicians

• summarise and synthesise evidence

• improve quality of clinical decisions

• support quality improvement activities

• identify future research needs

Woolf et al (1999). British Medical Journal.

Page 27: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

Guidelines :? Potential harms for Clinicians

• .

Page 28: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

Guidelines :Potential harms for Clinicians

• provide inaccurate summaries and syntheses of evidence

• reduce professionalism (cookbook medicine)

• medico-legal concerns

• economic impact

• discourage research Woolf et al (1999). British Medical Journal.

Page 29: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

Clinical Practice Guidelines Summary –Key Points

GRADE is the approach used by WHO and gaining acceptance internationally combines what is known in health research methodology and

provides a structured approach to improve communication

Guidelines should be based on the best available evidence to be evidence based

Does not avoid judgments but provides framework Criteria for evidence assessment across questions and

outcomes Criteria for moving from evidence to recommendations Transparent, systematic

four categories of quality of evidence two grades for strength of recommendations

Transparency in decision making and judgments is key

Page 30: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

International CPG Activities

Today -lets discuss this in the Croatian Context

? Try out the ‘Triple C’ idea

Guidelines that are ‘Cast in the Croatian Context’

Page 31: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

THANKYOU!

Page 32: with help from Jeremy Grimshaw, Gordon Guyatt, Andy ...croatia.cochrane.org/sites/croatia.cochrane.org/files/...with help from Jeremy Grimshaw, Gordon Guyatt, Andy Oxman, Jordi Pardo,

Determinants of confidence • RCTs • observational studies

• 5 factors that can lower quality

1. limitations in detailed study design and execution (risk of bias criteria)

2. Inconsistency (or heterogeneity) 3. Indirectness (PICO and applicability) 4. Imprecision 5. Publication bias

• 3 factors can increase quality 1. large magnitude of effect 2. opposing plausible residual bias or

confounding 3. dose-response gradient